| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/01/2008 | US20080103194 Anti-first-pass effect compounds |
| 05/01/2008 | US20080103193 Prodrug Delta 9-tetrahydrocannabinoic acid (THCA) converts to Delta 9-THC at 100 degrees C; extraction from marijuana with a supercritical, near-critical or critical fluid with or without cosolvents and purifying the cannabinoid-rich extracts by chromatography; improved first pass effect |
| 05/01/2008 | US20080103192 Conjugates of artemisinin-related endoperoxides and hydrazone derivatives for the treatment of cancer |
| 05/01/2008 | US20080103191 Entacapone-derivatives |
| 05/01/2008 | US20080103190 Thrombopoietin activity modulating compounds and methods |
| 05/01/2008 | US20080103189 Preparation and utility of substituted indoles |
| 05/01/2008 | US20080103188 Novel bicyclic compounds as modulators of androgen receptor function |
| 05/01/2008 | US20080103187 Reaction product of N-methylpyrrole, N-methylimidazole, 4-aminobutyric acid and B-alanine that can be folded into a U-shaped conformation at the gamma -aminobutyrate unit in a minor groove of a double helix region; conjugates with fluorescein isothiocyanate; antiproliferative agents; restenosis |
| 05/01/2008 | US20080103186 Novel crystalline forms of an antiviral benzimidazole compound |
| 05/01/2008 | US20080103185 Chloroacylation of 4-[(2,4-dioxothiazolidin-5-yl)methyl]phenoxyacetic acid; amidation of tert-butyl N-(2-amino-5-methoxyphenyl)-N-methylcarbamate; cyclizing to 5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}thiazolidine-2,4-dione; reflux purification; highly stable antidiabetic agents |
| 05/01/2008 | US20080103184 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 05/01/2008 | US20080103183 New imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 05/01/2008 | US20080103182 N-[1-(4-Difluoromethoxy-benzyl)-1H-indazol-3-yl]-terephthalamic acid;liver carnitine palmitoyl transferase 1 (L-CPT1) nhibitor; antidiabetic and hypotensive agent; obesity, insulin resistance, hyperglycemia; reduce liver beta -oxidation, consequently inhibit gluconeogenesis |
| 05/01/2008 | US20080103181 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide; viricide; with other active agents: interferons, ribavirin, immunoglobulins, immunomodulators, anti-inflammatory agents, antibiotics, antivirals or anti-infectious |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103179 For treating diabetes, hypertension, migraine, epilepsy, sleep apnea, depression, impulse control disorders or alcohol addiction; coadministering a sympathomimetic agent such as phentermine and an anticonvulsant sulfamate or sulfonylurea, preferably topiramate or zonisamide; side effect reduction |
| 05/01/2008 | US20080103178 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 05/01/2008 | US20080103177 New use of iloperidone |
| 05/01/2008 | US20080103176 N-{1-(3,5-Difluoro-benzyl)-3-[7-(2,2-dimethyl-propyl)-2-piperidin-1-yl-1,2,3,4-tetrahydro-naphthalen-1-ylamino]-2-hydroxy-propyl}-acetamide; 13-secretase inhibitor; Alzheimer's disease; inhibitors of beta-secretase, that inhibit beta-secretase-mediated cleavage of amiloid precursor protein APP |
| 05/01/2008 | US20080103175 7-((1h-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline |
| 05/01/2008 | US20080103174 Ether derivatives |
| 05/01/2008 | US20080103173 Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine |
| 05/01/2008 | US20080103172 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases |
| 05/01/2008 | US20080103171 Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof |
| 05/01/2008 | US20080103170 Nicotinic Acetylcholine Receptor Ligands |
| 05/01/2008 | US20080103169 Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| 05/01/2008 | US20080103168 phosphodiesterase inhibitor; antiinflammatory agent; 3-thia-10-aza-phenanthrenes and iintermediates 3-(3,4-dialkoxy-phenyl)-tetrahydro-thiopyran-4-one and 3-(3,4-dialkoxy-phenyl)-1,1-dioxo-hexahydro-1-thiopyran-4-ylamine, useful for its preparation |
| 05/01/2008 | US20080103167 Sulfonamide-Thiazolpyridine Derivatives As Glucokinase Activators Useful The Treatment Of Type 2 Diabetes |
| 05/01/2008 | US20080103166 Administering tropisetron to prevent and treat Schizophrenia, Alzheimer's, Parkinson's, and Huntington's Diseases,Tourette's Syndrome and Attention deficit disorder; antidepressants, anxiolytic and antiepileptic agents |
| 05/01/2008 | US20080103165 Ppar mediated modulation of neurogenesis |
| 05/01/2008 | US20080103164 methyl 6-chloro-1-(4-methylphenyl)-1,3,4,9-tetrahydro-2H- beta -carboline-2-carboxylate; antitumor agent; human papillomavirus, adenoviruses, retroviruses infections; sexually transmitted; head, neck cancers, skin cancers; warts, genital warts, cervical dysplasia, recurrent respiratory papillomatosis |
| 05/01/2008 | US20080103163 Nociceptine antagonists; hydrochloride salts of N-amidino-2-{[2-(4-chlorobenzoylamino)-6-methylquinazolin-4-yl]amino}cyclohexylamine, 1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one and N-(4-amino-2-methyl-6-quinolyl)-2-[(4-ethylphenoxy)methyl]benzamide |
| 05/01/2008 | US20080103162 Antipruritics |
| 05/01/2008 | US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/01/2008 | US20080103160 Of Src homology protein tyrosine phosphatase 1; phenyl isothiazolones or a benzo-1,4-quinone; antineoplastic agents; immunostimulants inducing a cytokine response; side effect reduction |
| 05/01/2008 | US20080103159 Composition Comprising Ocaperidone |
| 05/01/2008 | US20080103158 Methods for treating delaying the progression of alzheimer's disease with heterocyclic compounds |
| 05/01/2008 | US20080103157 3,3-dibenzylimidazo[1,2-a]pyridin-2(3H)-one; antidepressant, neuroprotectant, antiaging agent; manic depressive psychoses, obsessive-compulsive disorder; orally |
| 05/01/2008 | US20080103156 Bicyclic Heteroaromatic Compounds |
| 05/01/2008 | US20080103155 Pharmaceutical compositions for the treatment of sexual disorders II |
| 05/01/2008 | US20080103154 3, 4-dihydro-2(IH)-quinolinone and 2(1H)-quinolinone derivatives |
| 05/01/2008 | US20080103153 Combination of brimonidine and timolol for topical ophthalmic use |
| 05/01/2008 | US20080103152 7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-3,9-diazabicyclo [3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide; renin inhibitor; hypotensive agent, renal and cardial diseases, antidiabetic, antiinflammatory, anxiolitic agent, antidepressant |
| 05/01/2008 | US20080103151 Heterocyclic compounds and their uses as therapeutic agents |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103149 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/01/2008 | US20080103148 Preventing ventilator induced pneumonia; utilizing compounds having longer half life on mucosal surfaces |
| 05/01/2008 | US20080103147 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/01/2008 | US20080103146 Highly Selective Norepinephrine Reuptake Inhibitors And Methods Of Using The Same |
| 05/01/2008 | US20080103145 Administering racemic reboxetine component |
| 05/01/2008 | US20080103143 3-{[(5-Chloro-thiophene-2-carbonyl)-amino]-methyl}-[1,2,4]oxadiazole-5-carboxylic acid [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide; blood coagulation factor Xa and thrombin inhibitor, anticoagulant; thrombotic disorders: thrombosis, angina pectoris, myocardial infarction, stroke, arteriosclerosis |
| 05/01/2008 | US20080103142 c-Jun N-terminal kinase and cyclin-dependent kinase inhibitor; (4-benzotriazol-1-yl-5-chloro-pyrimidin-2-yl)-cyclohexyl-amine; antiinflammatory and anticarcinogenic agent; autoimmune and neurodegenerative disorders; rheumatoid arthritis, asthma, type II diabetes, Alzheimer's and Parkinson's diseases |
| 05/01/2008 | US20080103141 tert-Butyl 4-[({5-[4-(hydroxymethyl)phenyl]pyrimidin-2-yl}oxy)methyl]piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy, obesity; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080103140 Cyclohexylamides as Dopamine D3, D2 and 5Ht1a Antagonists |
| 05/01/2008 | US20080103139 3-Carbamoyl-2-Pyridone Derivative |
| 05/01/2008 | US20080103138 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103136 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 05/01/2008 | US20080103134 Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine |
| 05/01/2008 | US20080103133 4-OXO-2,3,4,5-TETRAHYDRO-BENZO[b][1,4]DIAZEPINE DERIVATIVES |
| 05/01/2008 | US20080103132 Fused heterocyclic compounds |
| 05/01/2008 | US20080103131 Therapeutically Active Thiophenepyrimidinone Compounds and Their Use |
| 05/01/2008 | US20080103130 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality |
| 05/01/2008 | US20080103129 Heterocyclic derived metalloprotease inhibitors |
| 05/01/2008 | US20080103128 Lactams substituted by cyclic succinates as inhibitors of abetta protein production |
| 05/01/2008 | US20080103127 Methods for treating disruptive behavior disorders |
| 05/01/2008 | US20080103126 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator |
| 05/01/2008 | US20080103125 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease |
| 05/01/2008 | US20080103124 Cefdinir-containing pharmaceutical composition |
| 05/01/2008 | US20080103123 4-phenyl-3-substituted pyridin compounds such as tert-Butyl 4-[({5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}oxy)methyl]-piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080103122 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 05/01/2008 | US20080103121 Storage stable, freeze dried material buffered by such sodium dihydrogen phosphate, citric acid and sodium hydroxide |
| 05/01/2008 | US20080103120 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickenier; extended time high blood serum concentration; rapidly absorbed gel |
| 05/01/2008 | US20080103119 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 05/01/2008 | US20080103118 Composition for improving blood cholesterol levels |
| 05/01/2008 | US20080103117 Two part dermatological pet shampoo formulations; accurate dispensing according to requirements |
| 05/01/2008 | US20080103116 Preventing birth defects; administering formulation to women from preconception through first trimester of pregnancy |
| 05/01/2008 | US20080103115 Phosphonate compounds |
| 05/01/2008 | US20080103114 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions |
| 05/01/2008 | US20080103113 Reduced level of background gene expression; responds to submicromolar concentrations of nonsteroidal ligand |
| 05/01/2008 | US20080103112 pressurizing deoxygenated suspension of particules and acetic acid and heating to form soluble material; higher dosage, reduced side effects; immunostimulants |
| 05/01/2008 | US20080103111 Increasing serotonin levels; utilizing tryptophan or 5-hydroxy derivative |
| 05/01/2008 | US20080103110 Water soluble prodrugs comprising therapeutics coupled via metabolically cleavable ester bond to proteins; extended blood half life; cancer, inflammation, infection, pain |
| 05/01/2008 | US20080103109 Distributing polynucleotide in vivo using conditional vector that is transcriptionally active in normal cells and not in malfunctioning cells |
| 05/01/2008 | US20080103108 Targeted artificial gene delivery |
| 05/01/2008 | US20080103107 Screening Methods |
| 05/01/2008 | US20080103106 Compositions and their uses directed to il-4r alpha |
| 05/01/2008 | US20080103105 Nervous system, neurodegenerative, and psychological disorders are treated using synergistic mixture of neurogenic agents; atorvastatin, cerivastatin, fluvastatin, simvastatin, lovastatin, pravastatin, rosuvastatin, or crilvastatin; and buspirone, ribavirin, tacrine, azakenpaullone, or folic acid |
| 05/01/2008 | US20080103104 Benzamide precursor with sulfur substituent; poly-ADP-ribose polymerase inhibitors, antitumor agents; leukemia, breast, ovarian, lung, bladder, prostate, pancreatic, and cervical cancers |
| 05/01/2008 | US20080103103 Administering to eye an effective amount of a catechin or polyphenol comprising epicatechin, epicatechin gallate, epigallocatechin, gallocatechin gallate, apigenin, anthocyanin, aurone, chalcone, isoflavone, proanthocyanidin, astringin, coumarin, stilbene, and/or xanthone; adenoviral infections; cancer |
| 05/01/2008 | US20080103102 Therapeutic compositions and methods of treatment with capsianoside-type compounds |
| 05/01/2008 | US20080103094 Targeted delivery of drugs for the treatment of viral infections |
| 05/01/2008 | US20080103086 Administering a protein kinase inhibitor or a protein phosphatase activator to prevent phosphorylation of high mobility group proteins; treating conditions associated with activation of the inflammatory cytokine cascade; septic shock, adult respiratory distress syndrome; diagnosis, prognosis |
| 05/01/2008 | US20080102162 Prebiotic Preparation |
| 05/01/2008 | US20080102137 natural composition adapted to modulate multiple pathophysiological processes in order to facilitate homeostatic glucose metabolism; comprising: vitamins; fatty acids; amino acids; phytochemicals; trace minerals; antioxidants; and metals |
| 05/01/2008 | US20080102134 comprising Fluvastatin Sodium, hydroxypropyl methylcellulose polymer and hydroxypropyl cellulose, wherein the granules are independent of particle size; capable of being stored at normal atmospheric conditions |
| 05/01/2008 | US20080102133 Oral Pharmaceutical Preparation for Proton Pump Antagonists |
| 05/01/2008 | US20080102131 oil component comprising water-insoluble bioactive substance is poly-dispersed while forming a domain in a matrix comprising water-soluble excipient based on water-soluble polymer, and sphericity of particulate not less than 0.9; powder characteristics allowing easy handling and high oral absorbability |
| 05/01/2008 | US20080102127 biodegradable polymer in combination with a hydrophobic lipid; Variation of the lipid and polymer types and variation in the ratio between the polymer and lipid components allows regulation of drug loading and release rate |